Glenn Gormley
CIK: 0002127198
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTS
Aktis Oncology, Inc.
Director
Discretionary Trading P&L
Holdings
About Gormley Glenn
Gormley Glenn (SEC CIK 0002127198) files insider reports with the SEC as Director of Aktis Oncology, Inc. (AKTS).
Signal8 holds 2 ownership filings by Gormley Glenn (1 Form 3, 1 Form 4), filed on Apr 16, 2026. Those filings report 1 transaction, the latest on Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gormley Glenn's filings is in BOSTON, MA.
Recent filings by Gormley Glenn
- Apr 15, 2026: Grant or award of AKTS derivative securities (Form 4, code A).
Other insiders filing for Aktis Oncology, Inc. (AKTS)
- Czibere Akos, Chief Medical Officer
- Herrmann Ken, Director
- Ron-Bigger Shulamit, Chief Operating Officer
- ELI LILLY & Co, 10% Owner
- Foley Todd, Director
- MPM BIOVENTURES 2018, L.P., 10% Owner